May 15th 2025
The poster presentations contain data highlighting the company’s role to date in developing non-replicating HSV-1 technology for use in neurology.
May 12th 2025
The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.
May 7th 2025
The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
May 6th 2025
Although automation is increasingly adopted in biomanufacturing, challenges remain in implementing it at the cell harvesting step.
Incorporating sustainable practices into process designs as early as possible ensures optimal performance.
The evolution of therapeutic modalities drives the adoption of single-use technologies.